✦ LIBER ✦

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial

✍ Scribed by Vik Khullar; Gerard Amarenco; Javier C. Angulo; Javier Cambronero; Kjetil Høye; Ian Milsom; Piotr Radziszewski; Tomasz Rechberger; Peter Boerrigter; Ted Drogendijk; Marianne Wooning; Christopher Chapple

Book ID: 118440998
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 827 KB
Volume: 63
Category: Article
ISSN: 0302-2838
DOI: 10.1016/j.eururo.2012.10.016

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Tolerability of Mirabegron,

Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European–Australian Phase 3 Trial

✍ Rovner, E.S. 📂 Article 📅 2013 🏛 Elsevier Science ⚖ 51 KB

Re: Efficacy and Tolerability of Mirabeg

Re: Efficacy and Tolerability of Mirabegron, a β3-Adrenoceptor Agonist, in Patients with Overactive Bladder: Results from a Randomised European-Australian Phase 3 Trial

✍ Wein, Alan J. 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 117 KB

886 THE EFFICACY AND TOLERABILITY OF MIR

886 THE EFFICACY AND TOLERABILITY OF MIRABEGRON IN PATIENTS WITH OVERACTIVE BLADDER – RESULTS FROM A EUROPEAN–AUSTRALIAN PHASE III TRIAL

✍ V. Khullar; J. Cambronero; P. Ströberg; J. Angulo; P. Boerrigter; M.B. Blauwet; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 226 KB

Onset of action of the β3-adrenoceptor a

Onset of action of the β3-adrenoceptor agonist, mirabegron, in Phase II and III clinical trials in patients with overactive bladder

✍ Chapple, Christopher R.; Nitti, Victor W.; Khullar, Vik; Wyndaele, Jean Jacques; 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 360 KB

1372 EFFICACY OF THE β3-ADRENOCEPTOR AGO

1372 EFFICACY OF THE β3-ADRENOCEPTOR AGONIST MIRABEGRON FOR THE TREATMENT OF OVERACTIVE BLADDER (OAB) IN PATIENTS WITH INCONTINENCE: PROSPECTIVE POOLED ANALYSIS OF 3 RANDOMIZED PHASE 3 TRIALS

✍ Nitti, Victor; Barkin, Jack; Van Kerrebroeck, Philip; Jeffrey, Frankel; Mitcheso 📂 Article 📅 2013 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 213 KB

MP33-04 EFFECTS OF THE β3-ADRENOCEPTOR A

MP33-04 EFFECTS OF THE β3-ADRENOCEPTOR AGONIST, MIRABEGRON, ON QUALITY OF LIFE IN OLDER PATIENTS WITH OVERACTIVE BLADDER: A POST-HOC ANALYSIS OF POOLED DATA FROM 3 RANDOMISED PHASE 3 TRIALS

✍ Wagg, Adrian; Nitti, Victor; Kelleher, Con; Auerbach, Stephen; Blauwet, Mary Bet 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 506 KB